HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tsukasa Matsubara Selected Research

bucillamine (SA 96)

1/2016The usefulness of a new triple combination treatment utilizing methotrexate, salazosulfapyridine, and bucillamine in rheumatoid arthritis.
1/2005Therapeutic effects of the combination of methotrexate and bucillamine in early rheumatoid arthritis: a multicenter, double-blind, randomized controlled study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tsukasa Matsubara Research Topics

Disease

38Rheumatoid Arthritis
11/2022 - 08/2003
4Infections
02/2022 - 01/2009
1Herpes Zoster
04/2022
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2022
1Necrosis
05/2020
1Psoriasis (Pustulosis Palmaris et Plantaris)
11/2016
1Glucose Intolerance
09/2015
1Metabolic Syndrome (Dysmetabolic Syndrome X)
09/2015
1Type 2 Diabetes Mellitus (MODY)
09/2015
1Hypersensitivity (Allergy)
03/2014
1Acute Disease
01/2014
1Symptom Flare Up
05/2013
1Surgical Wound Infection
11/2011
1Arthritis (Polyarthritis)
11/2011

Drug/Important Bio-Agent (IBA)

16Methotrexate (Mexate)FDA LinkGeneric
06/2022 - 01/2005
11Biological ProductsIBA
04/2022 - 01/2009
10Abatacept (Orencia)FDA Link
04/2022 - 03/2013
8Antirheumatic Agents (DMARD)IBA
06/2022 - 11/2011
6Adalimumab (Humira)FDA Link
02/2022 - 11/2012
6tocilizumab (atlizumab)FDA Link
05/2020 - 01/2009
4GLPG0634IBA
04/2022 - 01/2022
3Sulfasalazine (Azulfidine)FDA LinkGeneric
06/2022 - 02/2004
3Certolizumab PegolFDA Link
01/2021 - 01/2016
3Interleukin-6 (Interleukin 6)IBA
10/2020 - 01/2009
2AutoantigensIBA
01/2022 - 08/2003
2Tumor Necrosis Factor InhibitorsIBA
10/2020 - 05/2020
2Infliximab (Remicade)FDA Link
11/2019 - 11/2016
2Proteins (Proteins, Gene)FDA Link
01/2018 - 04/2015
2Biomarkers (Surrogate Marker)IBA
11/2016 - 09/2015
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2016 - 01/2009
2bucillamine (SA 96)IBA
01/2016 - 01/2005
2Peptides (Polypeptides)IBA
04/2015 - 08/2003
2AntibodiesIBA
04/2015 - 03/2014
2Monoclonal AntibodiesIBA
03/2014 - 01/2009
1Interleukin-6 InhibitorsIBA
11/2022
1iguratimodIBA
06/2022
1Anti-Citrullinated Protein AntibodiesIBA
04/2022
1omega-Chloroacetophenone (Mace)IBA
04/2022
1golimumabFDA Link
05/2020
1Biosimilar PharmaceuticalsIBA
11/2019
1Etanercept (Enbrel)FDA Link
03/2017
1Pharmaceutical PreparationsIBA
11/2016
1isomaltulose (palatinose)IBA
09/2015
1DextrinsIBA
09/2015
1Glucose (Dextrose)FDA LinkGeneric
09/2015
1Insulin (Novolin)FDA Link
09/2015
1Therapeutic UsesIBA
01/2005
1AcetyltransferasesIBA
02/2004
1Protein-Arginine DeiminasesIBA
08/2003
1AutoantibodiesIBA
08/2003
1EnzymesIBA
08/2003

Therapy/Procedure

4Therapeutics
08/2017 - 11/2012
2Orthopedic Procedures
01/2020 - 11/2011
1Retreatment
01/2014
1Perioperative Period
05/2013
1Operative Surgical Procedures
11/2011
1Arthroplasty
11/2011